Revised outcome of Board Meeting on 25th August 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma Ltd has submitted a revised version of the outcome of its Board Meeting held on 25th August 2025 to BSE. A revised outcome typically means the company corrected, updated, or supplemented an earlier disclosure originally filed with the exchange. Unfortunately, the detailed content of the revised decisions is not available in the provided text, so specific business actions (such as fundraising, appointments, or financial results) cannot be confirmed. Retail investors are advised to check the full revised filing on the BSE website for exact details of what was changed.
A revised board meeting outcome can sometimes create short-term uncertainty among investors, especially if the revision relates to a material decision like fundraising, results, or management change. Shareholders should review the complete document to understand whether the revision is minor (clerical) or substantive before reacting.